A Trial of Lopinavir-Ritonavir in Covid-19. Reply
- PMID: 32369286
- DOI: 10.1056/NEJMc2008043
A Trial of Lopinavir-Ritonavir in Covid-19. Reply
Comment on
-
A Trial of Lopinavir-Ritonavir in Covid-19.N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5. N Engl J Med. 2020. PMID: 32369281 No abstract available.
-
A Trial of Lopinavir-Ritonavir in Covid-19.N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5. N Engl J Med. 2020. PMID: 32369282 No abstract available.
-
A Trial of Lopinavir-Ritonavir in Covid-19.N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5. N Engl J Med. 2020. PMID: 32369283 No abstract available.
-
A Trial of Lopinavir-Ritonavir in Covid-19.N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5. N Engl J Med. 2020. PMID: 32369284 No abstract available.
-
A Trial of Lopinavir-Ritonavir in Covid-19.N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5. N Engl J Med. 2020. PMID: 32369285 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources